JENNIFER TATRAI: Open Payments
NPI 1871176347 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 23 payments from 9 companies in 2025. Trend: 2023 $163 · 2024 $252 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 7 | $185 |
| NxStage Medical, Inc. | 1 | $150 |
| AstraZeneca Pharmaceuticals LP | 2 | $139 |
| Vantive US Healthcare LLC | 1 | $128 |
| Amgen Inc. | 6 | $109 |
| AKEBIA THERAPEUTICS INC | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $15 |
Products named: NXSTAGE SYSTEM ONE, LOKELMA, XPHOZAH 30 MG, KRYSTEXXA, IBSRELA, Vafseo, JARDIANCE, TARPEYO.
Industry payments across AZ — which companies pay providers there.
